Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

Completed

Conditions studied: Stem Cell Transplant Complications, Hyperglycemia, Hypoglycemia

In brief

This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.

Key facts

Study ID

NCT03482154

Run by

University of Colorado, Denver

People needed

344

Starts

2016-09-06

Expected to finish

2019-06-30

Last updated by the study team

2019-09-30

Who can join

Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 0 to 30 years old at time of transplant
• Bone Marrow Transplant (BMT) recipient at Children's Hospital Colorado (CHCO) between 1/1/2007 and 7/31/2016

You may not qualify if…

• Preexisting diabetes mellitus or known hyperglycemia
• Inadequate blood glucose data for analysis

Where it is running

• Children's Hospital Colorado — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.